Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:865-870

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Medina, P.
Right arrow Articles by Lluch, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Medina, P.
Right arrow Articles by Lluch, S.

(Circulation. 1998;97:865-870.)
© 1998 American Heart Association, Inc.


Clinical Investigation and Reports

Arginine Vasopressin Enhances Sympathetic Constriction Through the V1 Vasopressin Receptor in Human Saphenous Vein

Pascual Medina, PhD; Antonio Acuña, BSc; Juan B. Martínez-León, MD; Eduardo Otero, MD; José M. Vila, PhD; Martín Aldasoro, MD; ; Salvador Lluch, MD

From the Department of Physiology (P.M., A.A., J.M.V., M.A., S.L.) and the Department of Surgery (J.B.M.-L., E.O.), University of Valencia (Spain).

Correspondence to S. Lluch, MD, Department of Physiology, Facultad de Medicina y Odontología, Avda Blasco Ibáñez 17, 46010 Valencia, Spain. E-mail medinap{at}post.uv.es

Background—Arginine vasopressin (AVP) not only acts directly on blood vessels through V1 receptor stimulation but also may modulate adrenergic-mediated responses in animal experiments in vivo and in vitro. The aim of the present study was to investigate whether AVP can contribute to an abnormal adrenergic constrictor response of human saphenous veins.

Methods and Results—Saphenous vein rings were obtained from 32 patients undergoing coronary artery bypass surgery. The vein rings were suspended in organ bath chambers for isometric recording of tension. AVP (3x10-9 mol/L) enhanced the contractions elicited by electrical field stimulation at 1, 2, and 4 Hz (by 80%, 70%, and 60%, respectively) and produced a leftward shift of the concentration-response curve to norepinephrine (half-maximal effective concentration decreased from 6.87x10-7 to 1.04x10-7 mol/L; P<.05). The V1 vasopressin receptor antagonist d(CH2)5Tyr(Me)AVP (10-6 mol/L) prevented the potentiation evoked by AVP. The selective V1 receptor agonist [Phe,2 Orn8]-vasotocin (3x10-9 mol/L) induced potentiation of electrical stimulation–evoked responses, which was also inhibited in the presence of the V1 receptor antagonist (10-6 mol/L). In contrast, the V2 receptor agonist desmopressin (10-9 to 10-7 mol/L) did not modify neurogenic responses, and the V2 receptor antagonist [d(CH2)5, D-Ile,2 Ile,4 Arg8]-vasopressin (10-8 to 10-6 mol/L) did not prevent the potentiation induced by AVP. The dihydropyridine calcium antagonist nifedipine (10-6 mol/L) did not affect the potentiating effect of AVP.

Conclusions—The results suggest that low concentrations of AVP facilitate sympathetic neurotransmission and potentiate constrictor effects of norepinephrine in human saphenous veins. These effects appear to be mediated by V1 receptor stimulation and are independent of calcium entry through dihydropyridine calcium channels. Thus, AVP may contribute to vascular mechanisms involved in acute ischemic syndromes associated with venous grafts, particularly if the sympathetic nervous system is activated.


Key Words: veins • arginine vasopressin • electrical stimulation • norepinephrine




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. Wei, C.-Q. Yang, A. Furnary, and G.-W. He
Greater vasopressin-induced vasoconstriction and inferior effects of nitrovasodilators and milrinone in the radial artery than in the internal thoracic artery
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 33 - 40.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Hirasawa and Q. J. Pittman
From the Cover: Nifedipine facilitates neurotransmitter release independently of calcium channels
PNAS, May 13, 2003; 100(10): 6139 - 6144.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Wei, H. S. Floten, and G.-W. He
Interaction between vasodilators and vasopressin in internal mammary artery and clinical significance
Ann. Thorac. Surg., February 1, 2002; 73(2): 516 - 522.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Tsuda, K. A. Tanaka, C. Huraux, F. Szlam, N. Sato, K. Yamaguchi, and J. H. Levy
The In Vitro Reversal of Histamine-Induced Vasodilation in the Human Internal Mammary Artery
Anesth. Analg., December 1, 2001; 93(6): 1453 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. M Vila, J. B Martinez-Leon, P. Medina, G. Segarra, R. M Ballester, E. Otero, and S. Lluch
U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: antagonism by thromboxane receptor blockade
Cardiovasc Res, December 1, 2001; 52(3): 462 - 467.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Segarra, P. Medina, C. Domenech, J. M. Vila, J. B. Martínez-León, M. Aldasoro, and S. Lluch
Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1315 - 1320.
[Abstract] [Full Text]